Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma
- PMID: 12386093
- PMCID: PMC1771371
- DOI: 10.1136/bjo.86.11.1299
Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma
Abstract
Aim: To investigate plasma indices of vascular permeability (vascular endothelial growth factor, VEGF-also an index of angiogenesis, as well as the soluble receptor for VEGF, sFlt-1) and endothelial damage/dysfunction (von Willebrand factor, vWf) in glaucoma.
Methods: Citrated plasma was assayed for VEGF, sFlt-1, and vWf (all ELISA) in a cross sectional study of 50 patients (20 male; mean age 63.9 years, SD 10.5) with glaucoma: 26 had normal tension glaucoma (NTG) and 24 had primary open angle glaucoma (POAG), who were compared with 26 healthy controls (mean age 73.4 years, SD 9.2).
Results: Median (interquartile range, IQR) levels of VEGF were significantly elevated in patients with NTG and POAG compared to healthy controls (Kruskal-Wallis test, p<0.001). Similarly, mean (SD) vWF levels were abnormal in NTG and POAG compared to healthy controls (one way ANOVA, p<0.001). Median levels of sFlt-1 were significantly lower in patients with NTG and POAG, when compared to healthy controls (Kruskal-Wallis test, p<0.001; p<0.05 with Tukey's post hoc test for controls v POAG). There were no significant differences in VEGF, sFlt-1 or vWf levels between the NTG and POAG groups (Tukey's test, all p=NS). In both NTG and POAG groups, there was a significant correlation between VEGF and sFlt-1 (Spearman, NTG: r=0.6517, p=0.001; POAG: r=0.6017, p=0.008). There were no significant correlations between VEGF and sFlt-1, or with vWf among the controls.
Conclusions: The pathogenesis of optic nerve damage in both NTG and POAG may be associated with abnormal vascular permeability and endothelial damage/dysfunction, as indicated by abnormal plasma VEGF and vWf levels in these patients.
Similar articles
-
Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2115-9. Invest Ophthalmol Vis Sci. 2000. PMID: 10892852
-
Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease.Heart. 2003 Dec;89(12):1411-5. doi: 10.1136/heart.89.12.1411. Heart. 2003. PMID: 14617549 Free PMC article.
-
Oedema extension in cerebral metastasis and correlation with the expression of nitric oxide synthase isozymes (NOS I-III).Anticancer Res. 2000 Jan-Feb;20(1A):305-10. Anticancer Res. 2000. PMID: 10769672
-
Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management.Am J Hypertens. 2003 Jan;16(1):11-20. doi: 10.1016/s0895-7061(02)03149-7. Am J Hypertens. 2003. PMID: 12517677
-
Glaucoma, Pseudoexfoliation and Hearing Loss: A Systematic Literature Review.J Clin Med. 2024 Feb 28;13(5):1379. doi: 10.3390/jcm13051379. J Clin Med. 2024. PMID: 38592217 Free PMC article. Review.
Cited by
-
Subconjunctival bevacizumab injection in glaucoma filtering surgery: a case control series.ISRN Ophthalmol. 2013 Mar 14;2013:384134. doi: 10.1155/2013/384134. eCollection 2013. ISRN Ophthalmol. 2013. PMID: 24563791 Free PMC article.
-
von Willebrand factor in iris vasculature of glaucoma patients.Med Sci Monit. 2014 Jun 23;20:1051-5. doi: 10.12659/MSM.890176. Med Sci Monit. 2014. PMID: 24954072 Free PMC article.
-
A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use.J Cell Mol Med. 2010 Mar;14(3):528-52. doi: 10.1111/j.1582-4934.2009.00941.x. Epub 2009 Oct 16. J Cell Mol Med. 2010. PMID: 19840194 Free PMC article. Review.
-
Ocular surface heat effects on ocular hemodynamics detected by real-time measuring device.Int J Ophthalmol. 2018 Dec 18;11(12):1902-1908. doi: 10.18240/ijo.2018.12.04. eCollection 2018. Int J Ophthalmol. 2018. PMID: 30588420 Free PMC article.
-
A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap.PLoS One. 2009;4(4):e5108. doi: 10.1371/journal.pone.0005108. Epub 2009 Apr 8. PLoS One. 2009. PMID: 19352513 Free PMC article.
References
-
- Carter CJ, Brooks DE, Doyle DL, Drance SM. Investigations into a vascular aetiology for low-tension glaucoma. Ophthalmology 1989;97:49–55. - PubMed
-
- Sonnsjo B, Krakau CE. Arguments for a vascular glaucoma aetiology. Acta Ophthalmol 1993;71:433–4. - PubMed
-
- Henry E, Newby EN, Webb DJ, et al. Peripheral endothelial dysFunction in normal pressure glaucoma. Invest Ophthalmol Vis Sci. 1999;40:17104. - PubMed
-
- Armaly MF. Lessons to be learned from the Collaborative Glaucoma Study. Surv Ophthalmol 1981;99:837–9. - PubMed
-
- Leske MC, Podgor MC. Intraocular pressure, cardiovascular risk variables and visual field defects. Am J Epidemiol 1983;118:280–7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous